| 000 | 04366cam a22003974i 4500 | ||
|---|---|---|---|
| 999 |
_c5503 _d5503 |
||
| 001 | 15762208 | ||
| 005 | 20201021112709.0 | ||
| 008 | 090603s2011 maua b 001 0 eng | ||
| 010 | _a 2009022814 | ||
| 020 | _a9780763761615 | ||
| 020 | _a0763761613 | ||
| 040 |
_aDNLM/DLC _cDLC _dYDX _dNLM _dDLC _erda |
||
| 050 | 0 | 0 |
_aRC683.5.C5 _bC37 2011 |
| 082 | 0 | 0 |
_a616.12075 _222 _bC |
| 245 | 0 | 0 |
_aCardiac biomarkers in clinical practice / _cedited by James L. Januzzi, Jr. |
| 264 | 1 |
_aSudbury, Mass. : _bJones and Bartlett Publishers, _c[2011] |
|
| 264 | 4 | _c©2011 | |
| 300 |
_axx, 892 pages : _billustrations (some color) ; _c21 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aSection One: Necrosis Markers -- Chapter 1: Biology of Standard Necrosis Markers -- Chapter 2: The Evolution and Revolution of Necrosis Markers in Modern Cardiology for the Diagnosis of Acute Myocardial Infarction -- Chapter 3: Biochemical and Analytical Issues for Cardiac Troponin -- Chapter 4: Utility of Troponin Testing for Risk Stratification and Treatment Decision Making in Acute Coronary Syndromes -- Chapter 5: Use of Cardiac Troponins in ST-Segment Elevation Myocardial Infarction -- Chapter 6: Interpretation of Cardiac Troponin Elevation in Patients with End-stage Renal Disease -- Chapter 7: Necrosis Market Testing in Heart Failure -- Chapter 8: Necrosis Markers in Conditions Other than Acute Coronary Syndromes and Heart Failure -- Chapter 9: Use of Cardiac Necrosis Biomarkers Following PCI or CABG -- Chapter 10: Emerging Biomarkers in Acute Coronoary Syndrome -- Chapter 11: Ischemia Markers -- Section Two: Inflammatory Markers -- Chapter 12: Inflammation and Inflammatory Markers in Cardiovascular Disease: From Bench to Bedside -- Chapter 13: Inflammation in The Development and Complications of Coronary Artery Disease -- Chapter 14: Role of Inflammatory Marker Testing in Acute Coronary Syndromes -- Chapter 15: Role of Inflammatory Biomarkers in heart Failure -- Section Three: Natriuretic Peptides -- Chapter 16: Biology of the Natriuretic Peptides -- Chapter 17: Natriuretic Peptide Testing: Laboratory Considerations -- Chapter 18: Natriuretic Peptides and Structural Heart Disease -- Chapter 19: Population Testing with Natriuretic Peptides -- Chapter 20: Natriuretic Peptide Testing in Symptomatic Primary Care Patients -- Chapter 21: Natriuretic Peptide Testing for Diagnostic Evaluation of Patients with suspected Acute Hearth Failure -- Chapter 22: Natriuretic Peptide Testing for Patients with Acute and Chronic Coronary Disease -- Chapter 23: Natriuretic Peptides and Prognostication: Predicting Outcomes Across the Spectrum of Medical Conditinos -- Chapter 24: Natriuretic peptides for Guidance of Acute and Chronic Heart Failure therapy -- Chapter 25: Natriuretic Peptide Testing in Patients with Renal Disease -- Chapter 26: Emerging Biomarkers of Cardiac Failure -- Section Four: Markers of Thrombosis and Hemostasis -- Chapter 27: Rationale for Clinical Measurement of Markers in Cardiology -- Chapter 28: Markers of Platelet Function and Assessment of Platelet Activation and Aggregation -- Section Five: Lipid Markers -- Chapter 29: Contemporary Interpretation of Lipid Guidelines in Modern Medicine -- Chapter 30: Biomarkers in the Metabolic Syndrome -- Chapter 31: Emerging Lipid-Based Biomarkers -- Section Six: The "-omics": Genomic, Metabolomic, and Protecomic Markers -- Chapter 32: Genetic Biomarkers | |
| 520 | _aCardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine | ||
| 650 | 0 |
_aHeart _xDiseases _xDiagnosis. |
|
| 650 | 0 |
_aBiochemical markers _xDiagnostic use. |
|
| 650 | 0 | _aClinical chemistry. | |
| 650 | 1 | 2 | _aBiological Markers. |
| 650 | 1 | 2 |
_aCardiovascular Diseases _xdiagnosis. |
| 650 | 2 | 2 |
_aCardiovascular Diseases _xprevention & control. |
| 650 | 2 | 2 | _aRisk Assessment. |
| 700 |
_aJanuzzi, James L. _933539 _eauthor. |
||
| 942 |
_cBK _2ddc |
||